Synonyms: CEP 1347 | CEP1347 | KT-7515 | KT7515 [5]
Compound class:
Synthetic organic
Comment: CEP-1347 is a semi-synthetic analogue of the natural alkaloid K-252a [5]. CEP-1347 was originally identified as a pan-mixed lineage kinase (MLK) family inhibitor [8]. In this setting it inhibits downstream c-jun N-terminal kinase (JNK) activation and has neuroprotective activity [1-2,7].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
CEP-1347 is often descrided as a selective inhibitor of mitogen-activated protein kinase kinase kinase 11 (MLK3), but in fact has inhibitory activity (> 99% inhibition) across all MLKs and a range of additional kinases [3]. The off-targets include leucine-rich repeat kinase 2 (LRRK2), fms-related tyrosine kinase 3 (FLT3), calcium/calmodulin-dependent protein kinase ID (CAMK1D), c-kit receptor tyrosine kinase (KIT) and Aurora kinases A and C [3]. We have tagged MLK1 as the primary molecular target for this compound for data metrics proposes only, and fully acknowledge its effect on other targets. |
Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|